CAGRI 10mg – Metabolic & Endocrine Signaling Research Support
 
CAGRI (Cagrilintide) is a high-purity, long-acting synthetic analog of the natural glucoregulatory hormone amylin, formulated for advanced metabolic and cellular research applications.
 
CAGRI is a non-selective amylin receptor agonist (NPARA) studied for its potent interaction with metabolic pathways and weight regulation mechanisms. It is extensively researched in experimental models for its role in suppressing glucagon secretion, delaying gastric emptying, and modulating appetite signaling within the central nervous system. Because of its unique structural modifications, it is a primary subject of investigation in studies focused on glycemic control and its potential synergistic effects when paired with other metabolic research compounds.
 
This advanced peptide is commonly utilized in research settings focused on endocrine signaling, obesity-related metabolic function, and the biochemical processes of energy homeostasis.
 
High purity (99.83% HPLC)
Research-grade quality (10.79mg net content)
White lyophilized powder for superior stability
Identity confirmed via LC-MS analysis
 
For laboratory research use only. Not for human or veterinary consumption.
 
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.